Grape King Bio Ltd (TPE:1707)

Grape King Bio Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	10,404	11,160	10,635	10,391	9,798	9,168
Revenue Growth (YoY)	-7.15%	4.93%	2.35%	6.05%	6.87%	-0.77%
Cost of Revenue	2,532	2,502	2,099	1,909	1,942	1,631
Gross Profit	7,872	8,658	8,536	8,482	7,856	7,537
Selling, General & Admin	5,419	5,866	5,747	5,639	5,252	4,979
Research & Development	292.54	291.91	289.55	289.88	292.23	252.86
Other Operating Expenses	-0.42	0.02	2.48	1.1	0.57	-0.05
Operating Expenses	5,711	6,158	6,039	5,930	5,544	5,232
Operating Income	2,161	2,500	2,497	2,552	2,312	2,305
Interest Expense	-4.24	-2.95	-2.45	-2.29	-3.93	-14.24
Interest & Investment Income	45.66	49.97	47.6	19.92	6.29	4.63
Earnings From Equity Investments	23.44	22.24	19.87	10.82	2.23	1.68
Currency Exchange Gain (Loss)	-1.61	7.38	0.67	11.63	-2.24	-6.17
Other Non Operating Income (Expenses)	91.58	94.13	98.9	94.1	99.35	87.95
EBT Excluding Unusual Items	2,316	2,671	2,661	2,686	2,413	2,379
Gain (Loss) on Sale of Investments	0.48	0.9	0.42	-1.91	0.8	-
Gain (Loss) on Sale of Assets	-0.13	0.62	-1.07	3.76	0.82	-0.46
Other Unusual Items	-	1.18	0.01	0.11	-	-
Pretax Income	2,316	2,673	2,661	2,688	2,415	2,378
Income Tax Expense	440.37	502.15	519.11	518.19	466.92	483.1
Earnings From Continuing Operations	1,876	2,171	2,142	2,170	1,948	1,895
Minority Interest in Earnings	-655.28	-722.85	-688.78	-712.58	-647.57	-623.07
Net Income	1,220	1,448	1,453	1,457	1,300	1,272
Net Income to Common	1,220	1,448	1,453	1,457	1,300	1,272
Net Income Growth	-16.98%	-0.30%	-0.30%	12.05%	2.23%	-2.83%
Shares Outstanding (Basic)	148	148	148	148	148	136
Shares Outstanding (Diluted)	149	149	149	149	148	137
Shares Change (YoY)	-0.06%	0.03%	0.04%	0.45%	8.41%	0.21%
EPS (Basic)	8.24	9.78	9.81	9.84	8.81	9.34
EPS (Diluted)	8.19	9.71	9.74	9.78	8.76	9.29
EPS Growth	-16.82%	-0.31%	-0.41%	11.64%	-5.71%	-3.03%
Free Cash Flow	1,749	1,249	1,932	2,504	2,267	1,505
Free Cash Flow Per Share	11.73	8.38	12.96	16.80	15.28	11.00
Dividend Per Share	6.400	6.900	6.900	6.900	6.100	6.400
Dividend Growth	-33.33%	-	-	13.11%	-4.69%	-1.54%
Gross Margin	75.66%	77.58%	80.26%	81.63%	80.18%	82.20%
Operating Margin	20.77%	22.40%	23.47%	24.56%	23.59%	25.14%
Profit Margin	11.73%	12.98%	13.66%	14.02%	13.27%	13.87%
Free Cash Flow Margin	16.81%	11.19%	18.17%	24.09%	23.14%	16.42%
EBITDA	2,616	2,933	2,885	2,936	2,679	2,658
EBITDA Margin	25.14%	26.28%	27.13%	28.26%	27.34%	28.99%
D&A For EBITDA	455.34	433.33	388.3	384.63	367.68	352.76
EBIT	2,161	2,500	2,497	2,552	2,312	2,305
EBIT Margin	20.77%	22.40%	23.47%	24.56%	23.59%	25.14%
Effective Tax Rate	19.02%	18.78%	19.51%	19.28%	19.34%	20.31%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.